bleeding
FDA Approves Fibryga for Acquired Fibrinogen Deficiency
The FDA expanded the approval for Fibryga to include fibrinogen replacement in bleeding patients with acquired ...
AUGUST 6, 2024
New Developments in Hemophilia Gene Therapy
Hemophilia is an X chromosome–linked genetic bleeding disorder caused by absent or defective clotting factor, ...
MAY 29, 2024
BioCareSD Adds Altuviiio to Its Specialty Therapeutics Portfolio
BioCareSD announced that Altuviiio is now available through its network.
APRIL 13, 2023
Load more